News Hunan Warrant Pharmaceutical Co.,Ltd

Equities

688799

CNE100004P73

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
42.97 ^CNY	+4.07%		+4.78%	-12.20%

28/05	Warrant Pharmaceutical's Unit Gets Nod to Market Benidipine Hydrochloride	MT
19/04	Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Warrant Pharmaceutical's Unit Gets Nod to Market Benidipine Hydrochloride	28/05	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	25/02	CI
Warrant Pharmaceutical's Diclofenac Tablets Passes Regulatory Evaluation	21/12	MT
Hunan Warrant Pharma Passes GMP Compliance Inspection	14/11	MT
Warrant Pharmaceutical's Heart Disease Medication Passes Generic Drug Evaluation in China	02/11	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	29/23/29	CI
Warrant Pharmaceutical Gets Nod to Market Clopidogrel Bisulfate	23/23/23	MT
Zhuhai Qianlie Pharmaceutical Co., Ltd. announced that it expects to receive CNY 25 million in funding from Hunan Warrant Pharmaceutical Co.,Ltd	16/23/16	CI
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	27/23/27	CI
Warrant Pharma Unit Registers Arthritis Drug in South Korea	12/23/12	MT
Warrant Pharma Secures Product Registration Certificate in South Korea	22/23/22	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	29/23/29	CI
Warrant Pharma Gets Regulatory Green Light to Issue Bonds	26/23/26	MT
Warrant Pharma Gets Registration Certificate in China for Asthma Drug	27/23/27	MT
Hunan Warrant Pharma Posts 12.2% Rise in 2022 Profit	24/23/24	MT
Hunan Warrant Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
Hunan Warrant Pharma's Drug Production Base Passes Regulator's GMP Inspection	09/23/09	MT
Hunan Warrant Pharma’s Hepatitis Drug Included in China’s Medical Insurance Catalog	19/23/19	MT
Hunan Warrant Pharma to Raise 691 Million Yuan For New Production Base	13/22/13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hunan Warrant Pharmaceutical Co.,Ltd

Equities

688799

CNE100004P73

Summary

Filters